Arcadia Biosciences Inc

Aktienanalyse zu Arcadia Biosciences Inc (RKDA)

$0.530

+0.018 (+3.33%)Zum Schluss

Loading chart…
High
0.549
Open
0.500
VWAP
0.53
Vol
157.41K
Mkt Cap
4.25M
Low
0.500
Amount
82.85K
EV/EBITDA, TTM
1.12

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

AI analysis of Arcadia Biosciences Inc (RKDA)

hold

Arcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.

Analyst Ratings (1)

Hold
0 Buy
1 Hold
0 Sell
Current: 0.53
Tief
Durchschnitt
Hoch

HC Wainwright & Co.

2024-08-21

Kursziel

$6

Strong Buy

HC Wainwright & Co.

2024-05-23

Kursziel

$6

Strong Buy

HC Wainwright & Co.

2024-04-05

Kursziel

$10

Strong Buy

HC Wainwright & Co.

2023-08-28

Kursziel

$10

Strong Buy

HC Wainwright & Co.

2023-07-24

Kursziel

$15

Strong Buy

Bewertungskennzahlen

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA) is 36.63, compared to its 5-year average forward P/E of 3.99.

Forward P/E

Strongly Overvalued
5Y Average P/E
3.99
Current P/E
36.63
Überbewertet
17.99
Unterbewertet
-10.02

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
0.36
Current EV/EBITDA
1.12
Überbewertet
1.12
Unterbewertet
-0.41

Forward P/S

Undervalued
5Y Average P/S
0.95
Current P/S
0.16
Überbewertet
1.62
Unterbewertet
0.28

Alphio AI Price Scenarios for RKDA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%RKDA

$5.40

Szenariopreis

B

Base

Base · 50%RKDA

$5.18

Szenariopreis

B

Bear

Bear · 25%RKDA

$5.10

Szenariopreis

Event-Zeitleiste

2026-06-26 (ET)

17:00:00

Arcadia Biosciences Files to Sell 11.92M Shares of Common Stock

2026-06-11 (ET)

21:00:00

Arcadia Biosciences Sells 3,883,496 Shares at $1.03 Each

2026-01-28 (ET)

06:10:00

Arcadia Biosciences Files to Sell 1.67M Shares of Common Stock

2026-01-20 (ET)

06:10:00

Rockwell Medical Sees Q4 Gross Margin Rise to 22%

2026-01-12 (ET)

08:50:00

Arcadia Biosciences Issues Preferred Investment Options, Raises Approximately $2.1M

News

RKDA FAQ — answered by Alphio AI

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour. It operates in the Consumer Non-Cyclicals sector.

Arcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.

1 analysts cover RKDA: 0 rate it Buy, 1 Hold and 0 Sell.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten